CARTIFUSE
Who is CARTIFUSE?
Medical device technology company developing a breakthrough cartilage regeneration technology to treat knee cartilage and osteochondral defects, with or without mild to moderate osteoarthritis with true hyaline cartilage regeneration.
Industry & Specialities
Manufacturing
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
SINGAPORE, SG
Employees by Department
Key Decision Makers
Simon Tyson
Chief Product Officer
Zhaotan Xiao
Chief Executive Officer
Lincoln Liow
Co-Founder and Chief Medical Advisor
Insight
Signals
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
3employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CARTIFUSE been operating for?
- What is the funding status of CARTIFUSE?
- Where is CARTIFUSE's headquarter?
- What CARTIFUSE's spending power?
- Does CARTIFUSE have a presence in the domain it operates in?